HomeTrading IdeasMarkets Today: RBNZ Rate...

Markets Today: RBNZ Rate Hold, Copper Volatility, DAX Moves Toward Fresh Highs

Chinese stocks are set to hit their highest level in three years as investors hope for new steps to fight deflation and boost the economy. Meanwhile, dropped in London after President Donald Trump issued a new tariff warning.

Asian Market Wrap

The Shanghai Stock Exchange Composite Index rose 0.4%, reaching its highest level this year and the best close since January 2022. The CSI 300 index, a key measure of Chinese stocks, is also set for its highest close since December. Data showed that China’s factory prices continued to fall for the 33rd month, but consumer prices surprisingly increased in June.

In other news, Asian stocks dipped slightly by 0.1% as investors avoided risky moves after Trump escalated trade tensions.

China’s weak inflation is putting pressure on policymakers to introduce more stimulus to break the cycle of falling prices, profits, and wages. Investors are now looking to Beijing’s July Politburo meeting for stronger economic support after recent efforts to cut factory overcapacity.

RBNZ Pauses Rate Cuts, NZD Slips Toward Two-Week Lows

The dropped to 0.598, near a two-week low, after the Reserve Bank of New Zealand paused its but hinted at more reductions if inflation slows.

The central bank kept its cash rate at 3.25%, following six cuts since August 2024. It’s being cautious due to 2.5% domestic inflation and global trade tensions that could raise prices.

However, the bank expects to lower rates further if inflation eases, and markets predict at least one more cut this year due to economic weakness.

European Open

European stocks edged up on Wednesday, boosted by defense shares, as investors watched for progress on a US-EU trade deal.

The index rose 0.2% to 546.94 points. Defense stocks gained 1.1%, banks climbed nearly 1%, and energy shares were up 0.8%.

President Trump hinted at announcing EU export tariffs soon, while reports suggest EU negotiators are close to a deal with higher tariffs than the UK.

EssilorLuxottica shares jumped 5.1% after Meta (NASDAQ:) reportedly acquired a 3% stake in the company.

On the FX front, the rose 0.1% to 146.75 yen, hitting 147.19 earlier, marking a 1.5% weekly gain, the biggest since December. Japan, heavily reliant on exports, remains far from a trade deal, with its currency, the , under pressure as talks stall and focus shifts to an upcoming election.

The stayed flat at 1.171 as the EU hopes to avoid U.S. tariffs and secure exemptions from the 10% baseline rate. The held steady at 97.60, while the edged up to 1.36. The New Zealand dollar also rose slightly to 0.60.

Currency Power Balance

Source: OANDA Labs

Looking at commodities and have recovered following a gap down over the weekend.

struggled overnight and has failed to hold above the $3300/oz handle as optimism grows around trade deals. Interesting data from the World Gold Council yesterday which showed that Global Central Bank buying remains strong.

Global central banks’ net gold purchases reached 20 tonnes in May, the highest in 3 months. This marks the 24th consecutive net monthly purchase.

Over the last year, central banks have bought an average of 27 tonnes of gold per month.

Economic Data Releases and Final Thoughts

Looking at the economic calendar, it remains a quiet one. The biggest events of the day will come from comments by Central Bank policymakers, with ECB and BoE policymakers on deck.

Later in the day, we have the as the Trump Administration continues to put pressure on the Fed publicly to .

Given the limited data releases, I am expecting tariff and trade deal chatter to dominate matters today and for the majority of the week ahead.Economic Calendar

MarketPulse Economic Calendar

Chart of the Day – DAX Index

From a technical standpoint, the DAX has been moving higher this morning on optimism that the EU will strike a deal with the Trump administration.

The is currently trading above the previous range high at 24330. A daily candle close above this level may lead to further upside.

Bulls do appear to be in control for now with trade talks ongoing.

A pullback to 24330 may provide bulls with potential long opportunities on an intraday basis. However, I would caution that without a daily candle close above the range (highlighted red/pink zone) a pullback toward the 24000 handle could materialize.

DAX Daily Chart, July 8, 2025Germany 30-Daily Chart

Source: TradingView.com

Support

Resistance

Original Post

Most Popular

More from Author

What To Expect From Eli Lilly’s Q2 Earnings – Eli Lilly (NYSE:LLY)

Eli Lilly and Co. LLY is set to release its second-quarter...

Amazon, Defense Stocks in Spotlight Amid Trade and Consumer Uncertainty

US stocks are modestly higher as investors weigh up the latest...

Rhythm Pharma’s Oral Drug For Rare Obesity Shows Promise – Rhythm Pharmaceuticals (NASDAQ:RYTM)

Rhythm Pharmaceuticals, Inc. RYTM on Wednesday released topline results from its...

Risk Assets Rebound as Trump Pushes Tariff Deadline to August 1

After a volatile past day session, this one was way calmer...

Read Now

What To Expect From Eli Lilly’s Q2 Earnings – Eli Lilly (NYSE:LLY)

Eli Lilly and Co. LLY is set to release its second-quarter earnings on August 7. According to Benzinga Pro data, analysts are anticipating adjusted earnings of $5.56 per share and sales of $14.4 billion.Expectations are slightly higher for the quarter, primarily driven by the strong performance of its obesity...

Amazon, Defense Stocks in Spotlight Amid Trade and Consumer Uncertainty

US stocks are modestly higher as investors weigh up the latest announcements from President Trump and watch for further trade developments. President Trump announced plans to impose 50% tariffs on imports, sending prices sharply higher. US copper prices shot 13% higher, closing at a record high of...

Rhythm Pharma’s Oral Drug For Rare Obesity Shows Promise – Rhythm Pharmaceuticals (NASDAQ:RYTM)

Rhythm Pharmaceuticals, Inc. RYTM on Wednesday released topline results from its Phase 2 trial evaluating bivamelagon (formerly LB54640), an investigational oral melanocortin-4 receptor (MC4R) agonist, in patients with acquired hypothalamic obesity.Hypothalamic obesity is a rare type of obesity resulting from damage to the hypothalamus, a brain region...

Risk Assets Rebound as Trump Pushes Tariff Deadline to August 1

After a volatile past day session, this one was way calmer as Trump announced yet another delay in tariff deadlines – From the approaching July 9th to August 1st, apparently the final warning. The session began with the leading to the upside, followed by general mean-reversion all...

Gilead’s Lenacapavir Plan Faces Global Hurdles As It Commits To No-Profit Access for 2 Million – Gilead Sciences (NASDAQ:GILD)

Gilead Sciences, Inc. GILD on Wednesday announced a strategic partnership agreement with the Global Fund to Fight AIDS, Tuberculosis and Malaria to supply lenacapavir — Gilead’s twice-yearly injectable HIV-1 capsid inhibitor — for the prevention of HIV as pre-exposure prophylaxis (PrEP).Through the agreement, Gilead will supply enough...

FDA Approves New Dosing Schedule For Eli Lilly’s Kisunla In Alzheimer’s Treatment – Eli Lilly (NYSE:LLY)

The U.S. Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for Eli Lilly and Co.’s LLY Kisunla (donanemab-azbt) once-monthly amyloid-targeting therapy for adults with early symptomatic Alzheimer’s disease (AD). The FDA approved the drug in July 2024.In the TRAILBLAZER-ALZ 6...

H2 2025: Room for Optimism, Risk for Complacency

Reasons To Be Fearful, Reasons To Be Cheerful It was an eventful first half of the year, to say the least... In January, the rise of DeepSeek was a wake-up call for the world, demonstrating that China is a major competitor to the US in AI and technology. The...

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug – Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA)

Merck & Co. Inc. MRK agreed on Wednesday to acquire Verona Pharma plc VRNA for $107 per American Depository Share (ADS) for a total transaction value of approximately $10 billion. Each ADS represents eight ordinary shares of Verona Pharma.Through the acquisition of this respiratory disease-focused company, Merck...

The Energy Report: Demand Exceeding Supply

It’s the oldest story in the book. Prices go up when demand exceeds supply, not only in oil and products but in wholesale power, driving up electricity costs. The Energy Information Administration (EIA) in its Short-Term Energy Outlook confirmed that we have a global supply deficit. Not only...

Altcoin Rotation Gains Steam as Bitcoin and Ethereum Take a Backseat

Despite increasing trade tensions and tariff worries, crypto continues to hold up. More than that, the group is actually performing pretty well. is leaning on a potential breakout, but it’s not doing the heavy lifting right now. To some extent, neither is . Instead, it’s more broad. Stellar,...

DAX Pushes Higher as EU Edges Closer to Tariff Deal With US

rises as investors await trade news from Trump. shows resilience despite a rise in inventories and uncertainty over trade tariffs. The DAX, along with European indices, is inching higher on Wednesday, supported by defence stocks as investors wait for news on a trade deal with the...

Oil Prices Near 2-Week Highs on OPEC+ Output and US Tariffs

climbed Tuesday, hovering near two-week highs as markets absorbed the impact of a larger-than-expected OPEC+ production increase and ongoing uncertainty around US trade policy. As of mid-afternoon, was up 89 cents at $70.47 per barrel, while US West Texas Intermediate rose 80 cents to $68.73. Both...